Khan Najat

Director · Officer · RXRX

As of 2026-09-27, Khan Najat has 22 Form 4 transactions on record across 1 company — 13 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $7.8MIndirect: $0$7.8Mas of 2026-09-27
  • Direct $7.8M
  • Indirect $0
RXRXdirect2,072,890 sh$7.8M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

RXRX · 22 trades
2026-09-08: Sale, 22,408 sh ($79K)2026-08-17: Withheld for tax, 80,498 sh ($254K)2026-06-05: Sale, 23,588 sh ($84K)2026-05-15: Withheld for tax, 62,701 sh ($191K)2026-03-09: Sale, 28,298 sh ($95K)2026-02-17: Withheld for tax, 14,280 sh ($50K)2026-02-06: Withheld for tax, 10,364 sh ($41K)2026-02-06: Award / grant, 1,673,546 sh ($0)2026-02-06: Award / grant, 30,346 sh ($0)2025-12-22: Sale, 124,403 sh ($549K)2025-11-17: Withheld for tax, 17,584 sh ($73K)2025-11-05: Award / grant, 169,851 sh ($0)2025-11-05: Award / grant, 84,925 sh ($0)2025-08-18: Sale, 36,599 sh ($202K)2025-08-15: Withheld for tax, 3,789 sh ($21K)2025-05-15: Withheld for tax, 3,796 sh ($16K)2025-02-03: Withheld for tax, 2,753 sh ($20K)2025-02-03: Award / grant, 8,049 sh ($0)2025-02-03: Award / grant, 420,226 sh ($0)2025-02-03: Award / grant, 210,113 sh ($0)2024-08-01: Award / grant, 993,944 sh ($0)2024-08-01: Award / grant, 496,972 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-09-08RXRXSale22,408 @ $3.52$79K−1.1% of holding2,072,890Form 4
2026-06-05RXRXSale23,588 @ $3.58$84K−1.1% of holding2,175,796Form 4
2026-03-09RXRXSale28,298 @ $3.35$95K−1.2% of holding2,262,085Form 4
2025-12-22RXRXSale124,403 @ $4.41$549K−16.9% of holding611,135Form 4
2025-08-18RXRXSale36,599 @ $5.52$202K−5.2% of holding668,197Form 4
17 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-08-17RXRXWithheld for tax80,4982,095,298Form 4
2026-05-15RXRXWithheld for tax62,7012,199,384Form 4
2026-02-17RXRXWithheld for tax14,2802,290,383Form 4
2026-02-06RXRXWithheld for tax10,3642,304,663Form 4
2026-02-06RXRXAward / grant1,673,5462,284,681Form 4
2026-02-06RXRXAward / grant30,3462,315,027Form 4
2025-11-17RXRXWithheld for tax17,584735,538Form 4
2025-11-05RXRXAward / grant169,851169,851Form 4
2025-11-05RXRXAward / grant84,925753,122Form 4
2025-08-15RXRXWithheld for tax3,789704,796Form 4
2025-05-15RXRXWithheld for tax3,796708,585Form 4
2025-02-03RXRXWithheld for tax2,753712,381Form 4
2025-02-03RXRXAward / grant8,049715,134Form 4
2025-02-03RXRXAward / grant420,226420,226Form 4
2025-02-03RXRXAward / grant210,113707,085Form 4
2024-08-01RXRXAward / grant993,944993,944Form 4
2024-08-01RXRXAward / grant496,972496,972Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.